Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
54 hedge funds and large institutions have $19.5M invested in Applied Genetic Technologies Corporation in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 15 closing their positions.
5,733% more call options, than puts
Call options by funds: $175K | Put options by funds: $3K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 61 → 54 (-7)
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
67% less capital invested
Capital invested by funds: $59M → $19.5M (-$39.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$823K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$666K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$549K |
| 4 |
Two Sigma Investments
New York
|
+$476K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$403K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$1.06M |
| 2 |
Man Group
London,
United Kingdom
|
-$946K |
| 3 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$754K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$549K |
| 5 |
Millennium Management
New York
|
-$491K |
AGTC Hedge Fund Activity: Q4 2018 in Review
54 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2018, worth a combined $19.5M — down 67% from $59M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AGTC and 8 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 12 added.
The largest buyer was Renaissance Technologies, adding an estimated $823K. The largest seller was Wells Fargo, cutting an estimated $1.06M.
- 54 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2018, down from 61 in Q3 2018.
- Funds reported $19.5M of Applied Genetic Technologies Corporation stock for Q4 2018, down 67% quarter-over-quarter.
- 8 funds opened new Applied Genetic Technologies Corporation positions in Q4 2018 and 15 closed out, a net change of -7 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q4 2018 was Renaissance Technologies, an estimated $823K added.
- The largest Applied Genetic Technologies Corporation seller in Q4 2018 was Wells Fargo, an estimated $1.06M sold.
Based on aggregated 13F filings for Q4 2018.